-transparent.png){kind=logo}
A double blind study in 28 patients with chronic schizophrenia was carried out comparing L-dopa (up to 1250 mgm daily) with placebo (both groups continuing to receive regular neuroleptic medication) over a six week period. Assessments by the psychiatrists and psychologist using Rockland and Pollin Rating Scale showed differential improvement of insignificant proportions but the nurse's ratings showed clearly significant improvement in the subject group.
Related Publications
F H Buchanan, and
R V Parton, and
J W Warren, and
E P Baker
January 1975,
Folia psychiatrica et neurologica japonica,
F H Buchanan, and
R V Parton, and
J W Warren, and
E P Baker
December 1973,
The New Zealand medical journal,
F H Buchanan, and
R V Parton, and
J W Warren, and
E P Baker
January 1977,
The New Zealand medical journal,
F H Buchanan, and
R V Parton, and
J W Warren, and
E P Baker
September 1994,
Internal medicine (Tokyo, Japan),
F H Buchanan, and
R V Parton, and
J W Warren, and
E P Baker
February 1969,
The British journal of psychiatry : the journal of mental science,
F H Buchanan, and
R V Parton, and
J W Warren, and
E P Baker
December 1970,
The British journal of psychiatry : the journal of mental science,
F H Buchanan, and
R V Parton, and
J W Warren, and
E P Baker
November 1975,
Diseases of the nervous system,
F H Buchanan, and
R V Parton, and
J W Warren, and
E P Baker
November 1971,
Ugeskrift for laeger,
F H Buchanan, and
R V Parton, and
J W Warren, and
E P Baker
October 1995,
Sleep,
F H Buchanan, and
R V Parton, and
J W Warren, and
E P Baker
June 1986,
Biological psychiatry,
